Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP902787.RAoQ8Rl1cSTIdd_0NtGcb_pr1q5Z8sKJ9MEA9PaP-LWt0130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP902787.RAoQ8Rl1cSTIdd_0NtGcb_pr1q5Z8sKJ9MEA9PaP-LWt0130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP902787.RAoQ8Rl1cSTIdd_0NtGcb_pr1q5Z8sKJ9MEA9PaP-LWt0130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP902787.RAoQ8Rl1cSTIdd_0NtGcb_pr1q5Z8sKJ9MEA9PaP-LWt0130_provenance.
- NP902787.RAoQ8Rl1cSTIdd_0NtGcb_pr1q5Z8sKJ9MEA9PaP-LWt0130_assertion description "[Including this patient, we administered 150 mg erlotinib daily to nine NSCLC patients with CNS metastases and measured the plasma and CSF concentrations just before administration on day 8.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP902787.RAoQ8Rl1cSTIdd_0NtGcb_pr1q5Z8sKJ9MEA9PaP-LWt0130_provenance.
- NP902787.RAoQ8Rl1cSTIdd_0NtGcb_pr1q5Z8sKJ9MEA9PaP-LWt0130_assertion evidence source_evidence_literature NP902787.RAoQ8Rl1cSTIdd_0NtGcb_pr1q5Z8sKJ9MEA9PaP-LWt0130_provenance.
- NP902787.RAoQ8Rl1cSTIdd_0NtGcb_pr1q5Z8sKJ9MEA9PaP-LWt0130_assertion SIO_000772 21681573 NP902787.RAoQ8Rl1cSTIdd_0NtGcb_pr1q5Z8sKJ9MEA9PaP-LWt0130_provenance.
- NP902787.RAoQ8Rl1cSTIdd_0NtGcb_pr1q5Z8sKJ9MEA9PaP-LWt0130_assertion wasDerivedFrom befree-2016 NP902787.RAoQ8Rl1cSTIdd_0NtGcb_pr1q5Z8sKJ9MEA9PaP-LWt0130_provenance.
- NP902787.RAoQ8Rl1cSTIdd_0NtGcb_pr1q5Z8sKJ9MEA9PaP-LWt0130_assertion wasGeneratedBy ECO_0000203 NP902787.RAoQ8Rl1cSTIdd_0NtGcb_pr1q5Z8sKJ9MEA9PaP-LWt0130_provenance.
- befree-2016 importedOn "2016-02-19" NP902787.RAoQ8Rl1cSTIdd_0NtGcb_pr1q5Z8sKJ9MEA9PaP-LWt0130_provenance.